Introduction
Hidradenocarcinoma is very rare and slow growing tumor of sweat gland.1 Most commonly it involves scalp (40%) followed by face (30%) and rarely present on extremities.2 Most of the cases arises de novo, in rare condition it may arises from preexisting hidroadenoma.3, 4 It is locally aggressive and can recurre after complete exicision. The written consent was taken from patient.
Case Report
A 27-year old postpartum female patient presented with complain of swelling over right breast since 8 months with increasing in size associated with pain on and off. On physical examination, 2 x 1 cm sized swelling in inner lower quadrant of right breast, irregular in shape, smooth margin, firm to hard on palpation with normal overlying skin.
Ultrasonography of breast showed, well defined hypoechoic lesion with minimum internal vascularity and posterior acoustic enhancement at lower inner quadrant of right breast with possibility of fibroadenoma (BIRADS II). Patient underwent a diagnostic fine niddle aspiration cytology and it shows Category-III: Atypical [The International Academy of cytology Yakohama system for reporting for Breast FNAC (2020)] and biopsy was adviced.
Gross
The specimen measures 4.3 x 3.6 x 1.4 cm with one friable nodule measuring 2 x 1.6 cm. On cut section from nodular area whitish growth measuring 1.7 x 1.1 cm identified.
Microsopic examination
Histopathological sections from right breast mass show neoplastic cells arranged in solid sheets and variably sized nodules in infiltrative growth pattern. There is a presence of microscopic heterogenicity in both its cellular composition and cytological grade. The cellular composition shows neoplastic cells composed of squamoid cells, transitional elements and at places clear cells. There is a presence of glandular component recognized by having round glands devoid of epithelial cells with intracytoplasmic lumina. With regard to cytological grade, both low and high grade tumor cells recognized. Focal duct formation, sclerosis of stroma and entrapped hyalinized vascular structure are evident.5 Atypical mitosis are also seen (22/10 HPF). Surgical margins are free from tumor. No evidence of ductal carcinoma insitu identified. Surrounding breast shows lactational changes. Overall findings reported as a Malignant epithelial neoplasm, adnexal origin – Hidradenocarcinoma type. Separately received total 11 lymphnodes were free from tumor. Immunohistochemistry was advised to confirm the diagnosis.
Discussion
Hidradenocarcinoma is very rare malignant intradermal tumor of breast having equal incidence in male and female of 5th to 7th decade. It mimics to breast carcinoma clinically and radiologically. It is diagnostic challenging and confirmed only after complete excision.It is slow growing solitary painless nodule with or without overlying skin changes.6, 7
It shows distant metastasis to regional lymphnode, lung, bone, brain, viscera, skin.8 Hidradenocarcinoma are usually larger, asymmetric, and show infiltrative growth pattern into surrounding tissue.9 Histologically, it shows lobulated mass with solid, cystic areas, cytological atypia with solid papillary architecture along with benign counterpart. The tumor is composed of polyhedral, squamoid, clear, poroid / transitional and rarely mucinous cells.10 To diagnose malignancy, there should be infiltrative growth pattern, deep extension, nuclear pleomorphism, necrosis, vascular or perineural invasion, Mitosis of 4 or more/ 10 HPF, Ki -67 > 11%, PHH3 > 0.7% reported in malignant cases.11 Immunohistochemistry studies are usually positive for cytokeratins, CEA, EMA, GCDFP-15 and p63, but negative for vimentin. Screening for HER2 overexpression and estrogen receptors should be considered in the tumor sample due to its potential usefulness.12 Hidradenocarcinoma stains with AE1/ AE3, CK5, and CK6 with high Ki- 67 expression helps to distinguish it from atypical hidradenoma. Metastatic clear cell carcinoma of thyroid, lung and kidney mimics to clear cell hidradenocarcinoma; TTF – 1 may be useful to differentiate hidradenocarcinoma from thyroid and lung carcinomas.13 Early diagnosis and treatment are the two variables which influence long-term prognosis. Survival depends on the size and the systemic dissemination of the tumor. The only treatment that has been shown to positively influence survival is extensive surgical resection of the tumor (margins between 3 and 5cm are recommended to ensure negativity). Diagnostic surgery is usually performed, requiring a second intervention to extend margins and study the lymph nodes once the tumor type has been determined.14 The study of the sentinel lymph node is recommended4 requiring lymphadenectomy associated with radiotherapy in case of involvement.
Adjuvant treatment with chemotherapy and radiotherapy should only be considered in cases of large tumor size, high-risk histopathological characteristics or metastasis at the time of diagnosis.3